Mutant RAS inhibits neutrophil but not macrophage differentiation and allows continued growth of neutrophil precursors

Experimental Hematology

Volumn 27, Issue 11, 1999, Pages 1599-1608

  Darley, Richard L ^a   Burnett, Alan K ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Differentiation; Leukemia; Macrophage; Neutrophil; RAS

Indexed keywords

CYTARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ARTICLE; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL RENEWAL; CONTROLLED STUDY; GENE ACTIVATION; GENE MUTATION; HUMAN; HUMAN CELL; LEUKEMOGENESIS; LEUKOPOIESIS; MACROPHAGE; MYELOID LEUKEMIA; NEUTROPHIL; ONCOGENE RAS; PRIORITY JOURNAL; STEM CELL;

CELL CYCLE; CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; GENES, RAS; HUMANS; MACROPHAGES; MUTATION; NEUTROPHILS; STEM CELLS;

ARA;

EID: 0032701282     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(99)00100-9     Document Type: Article

References (42)

1. Tenen D.G., Hromas R., Licht J.D., Zhang D.E. Transcription factors, normal myeloid development, and leukemia. Blood. 90:1997;489.
2. Kiaris H., Spandidos D.A. Mutations of ras genes in human tumours. Int J Oncol. 7:1995;413.
3. Bartram C.R. Molecular genetic aspects of myelodysplastic syndromes [Review]. Hematol Oncol Clin North Am. 6:1992;557.
4. Shen W.P.V., Aldrich T.H., Venta-Perez G., Franza B.R., Furth M.E. Expression of normal and mutant ras proteins in human acute leukaemia. Oncogene. 1:1987;157.
5. Gallagher A.P., Padua R.A., Alsabah A., Burnett A.K., Darley R.L. Overexpression of p21RAS but not p120GAP is a common feature of myelodysplasia. Leukemia. 9:1995;1833.
6. Zhang Y.Y., Vik T.A., Ryder J.W., Srour E.F., Jacks T., Shannon K., Clapp D.W. Nf1 regulates hematopoietic progenitor cell growth and Ras signaling in response to multiple cytokines. J Exp Med. 187:1998;1893.
7. Goga A., McLaughlin J., Afar D.E.H., Saffran D.C., Witte O.N. Alternative signals to RAS for haematopoietic transformation by BCR-ABL oncogene. Cell. 82:1995;981.
8. Darley R.L., Hoy T.G., Baines P., Padua R.A., Burnett A.K. Mutant N-RAS induces erythroid lineage dysplasia in human CD34(+) cells. J Exp Med. 185:1997;1337.
9. Mackenzie M.L., Dolnikov A., Millington M., Shounan Y., Symonds G. Mutant N-ras induces myeloproliferative disorders and apoptosis in bone marrow repopulated mice. Blood. 93:1999;2043.
10. Gallagher A.G., Bowen D.T., Burnett A.K., Darley R.L. Mutant RAS selectively promotes sensitivity of myeloid leukaemia cells to apoptosis by a protein kinase-C-dependent process. Cancer Res. 58:1998;2029.
11. Maher J., Colona F., Baker D., Luzzatto L., Roberts I. Retroviral-mediated gene transfer of a mutant H-ras gene into normal human bone marrow alters myeloid cell proliferation and differentiation. Exp Hematol. 22:1994;8.
12. Kinoshita T., Yokota T., Arai K.I., Miyajima A. Regulation of Bcl-2 expression by oncogenic Ras protein in hematopoietic-cells. Oncogene. 10:1995;2207.
13. Heyworth C.M., Dexter T.M., Kan O., Whetton A.D. The role of hemopoietic growth factors in self-renewal and differentiation of IL-3-dependent multipotential stem cells. Growth Factors. 2:1990;197.
14. Heyworth C.M., Alauldin M., Cross M.A., Fairbairn L.J., Dexter T.M., Whetton A.D. Erythroid development of the FDCP-mix A4 multipotent cell-line is governed by the relative concentrations of erythropoietin and interleukin-3. Br J Haematol. 91:1995;15.
15. Compere S.J., Baldacci P.A., Sharpe A.H., Jaenisch R. Retroviral transduction of the human c-Ha-ras-1 oncogene into midgestation mouse embryos promotes rapid epithelial hyperplasia. Mol Cell Biol. 9:1989;6.
16. Kiem H.P., Darovsky B., Vonkalle C., Goehle S., Stewart D., Graham T., Hackman R., Appelbaum F.R., Deeg H.J., Miller A.D., Storb R., Schuening F.G. Retrovirus-mediated gene transduction into canine peripheral-blood repopulating cells. Blood. 83:1994;1467.
17. Spooncer E., Heyworth C.M., Dunn A., Dexter T.M. Self-renewal and differentiation of interleukin-3-dependent multipotent stem cells are modulated by stromal cells and serum factors. Differentiation. 31:1986;111.
18. Watson J.V., Chambers S.H., Smith P.J. A pragmatic approach to the analysis of DNA histograms with a definable G1 peak. Cytometry. 8:1987;1.
19. Darzynkiewicz Z., Juan G., Li X., Gorczyca W., Murakami T., Traganos F. Cytometry in cell necrobiology. analysis of apoptosis and accidental cell death (necrosis) Cytometry. 27:1997;1.
20. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 7.43.
21. Spooncer E., Boettiger D., Dexter T.M. Isolation and culture of factor-dependent haemopoietic cell lines. Testa N.G., Molineux G. Haemopoiesis. 1993;107 IRL press, Oxford.
22. Shearman M.S., Heyworth C.M., Dexter T.M., Haefner B., Owen P.J., Whetton A.D. Hematopoietic stem-cell development to neutrophils is associated with subcellular redistribution and differential expression of protein- kinase-C subspecies. J Cell Sci. 104:1993;173.
23. Wickramasinghe SN (1975) Neutrophil granulopoiesis. In: Human bone marrow. Oxford: Blackwell, 111.
24. Cambier N., Chopra R., Strasser A., Metcalf D., Elefanty A.G. BCR-ABL activates pathways mediating cytokine independence and protection against apoptosis in murine hematopoietic cells in a dose- dependent manner. Oncogene. 16:1998;335.
25. Mavilio F., Kreider B.L., Valtieri M., Naso G., Shirsat N., Venturelli D., Reddy E.P., Rovera G. Alteration of growth and differentiation factors response by kirsten and harvey sarcoma-viruses in the Il-3-dependent murine hematopoietic-cell line 32d-c13(G). Oncogene. 4:1989;301.
26. Andrejauskas E., Moroni C. Reversible abrogation of IL-3 dependence by an inducible H-RAS oncogene. EMBO J. 8:1989;2575.
27. Minden M. Growth-factor requirements for normal and leukemic-cells. Semin Hematol. 32:1995;162.
28. Testa U., Fossati C., Samoggia P., Masciulli R., Mariani G., Hassan H.J., Sposi N.M., Guerriero R., Rosato V., Gabbianelli M., Pelosi E., Valtieri M., Peschle C. Expression of growth factor receptors in unilineage differentiation culture of purified hematopoietic progenitors. Blood. 88:1996;3391.
29. Evans C.A., Pierce A., Winter S.A., Spooncer E., Heyworth C.M., Whetton A.D. Activation of GM-CSF and IL-3 receptor subunits in a multipotential hemopoietic progenitor cell line leads to differential effects on development. Blood. 94:1999;1504.
30. Foley K.P., McArthur G.A., Queva C., Hurlin P.J., Soriano P., Eisenman R.N. Targeted disruption of the MYC antagonist MAD1 inhibits cell cycle exit during granulocyte differentiation. EMBO J. 17:1998;774.
31. Lloyd A.C. Ras versus cyclin-dependent kinase inhibitors. Curr Opin Genet Dev. 8:1998;43.
32. Ihle J.N. Signaling by the cytokine receptor superfamily in normal and transformed hematopoietic-cells. Adv Cancer Res. 68:1996;23.
33. deKoning J.P., SoedeBobok A.A., Schelen A.M., Smith L., vanLeeuwen D., Santini V., Burgering B.M.T., Bos J.L., Lowenberg B., Touw I.P. Proliferation signaling and activation of Shc, p21Ras, and myc via tyrosine 764 of human granulocyte colony-stimulating factor receptor. Blood. 91:1998;1924.
34. Itoh T., Muto A., Watanabe S., Miyajima A., Yokota T., Arai K. Granulocyte-macrophage colony-stimulating factor provokes RAS activation and transcription of c-fos through different modes of signaling. J Biol Chem. 271:1996;7587.
35. AlShami A., Mahanna W., Naccache P.H. Granulocyte-macrophage colony-stimulating factor-activated signaling pathways in human neutrophils - selective activation of Jak2, Stat3, and Stat5B. J Biol Chem. 273:1998;1058.
36. Ward A.C., Hermans M.H.A., Smith L., vanAesch Y.M., Schelen A.M., Antonissen C., Touw I.P. Tyrosine-dependent and -independent mechanisms of STAT3 activation by the human granulocyte colony-stimulating factor (G-CSF) receptor are differentially utilized depending on G-CSF concentration. Blood. 93:1999;113.
37. Shimozaki K., Nakajima K., Hirano T., Nagata S. Involvement of STAT3 in the granulocyte colony-stimulating factor- induced differentiation of myeloid cells. J Biol Chem. 272:1997;25184.
38. Hibi S., Lohler J., Friel J., Stocking C., Ostertag W. Induction of monocytic differentiation and tumorigenicity by v- Ha-ras in differentiation-arrested haematopoietic cells. Blood. 81:1993;1841.
39. Maher J., Baker D., Dibb N., Roberts I. Mutant ras promotes haemopoietic cell proliferation or differentiation in a cell-specific manner. Leukemia. 10:1996;83.
40. Bos J.L. Ras oncogenes in human cancer. a review Cancer Res. 49:1989;4682.
41. Whetton A.D., Heyworth C.M., Nicholls S.E., Evans C.A., Lord J.M., Dexter T.M., Owenlynch P.J. Cytokine-mediated protein-kinase-C activation is a signal for lineage determination in bipotential granulocyte-macrophage colony-forming cells. J Cell Biol. 125:1994;651.
42. Pierce A., Heyworth C.M., Nicholls S.E., Spooncer E., Dexter T.M., Lord J.M., Owenlynch P.J., Wark G., Whetton A.D. An activated protein kinase C alpha gives a differentiation signal for hematopoietic progenitor cells and mimicks macrophage colony- stimulating factor-stimulated signaling events. J Cell Biol. 140:1998;1511.